Supernus Pharmaceuticals Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 11 of 11 Posts
E 4 Mental Health Stocks Got My Mind Made Up
Article By: Sunil Tinani Friday, November 13, 2020 4:45 AM EST
The WHO has urged nations to increase their investment in mental healthcare services, or risk facing an upsurge of cases. Biotech and service companies in the mental healthcare niche are expected to do well in the medium to long term.
In this article: ITCI, ACHC, SUPN, GWPH
Read
How To Identify Short Candidates Through Anomalous Insider Selling Activity
Article By: Sabrient Systems Tuesday, January 7, 2020 11:03 PM EST
Perhaps the most reliable shortcut to identifying a company at elevated risk of a downturn in its share price is looking at how executives and directors use their equity instruments.
In this article: SUPN, USM, MGLN, AMRN, OSUR, MYRG
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA Friday, May 18, 2018 8:41 PM EST
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
Supernus Pharmaceutical - Chart Of The Day
Article By: Jim Van Meerten Wednesday, September 6, 2017 2:05 PM EST
Since the Trend Spotter signaled another buy in 8/16 the stock gained 2.96%.
In this article: SUPN
Read
Biotechs Are Looking Interesting Here…
Article By: Michael Lamothe Monday, June 5, 2017 9:47 AM EST
Growth stock scans on ChartYourTrade MRI.
In this article: NVO, OSUR, SUPN
Read
Biotechs Fade Again In Late Day Sell-Off
Article By: Rod Raynovich Monday, December 19, 2016 8:51 PM EST
Biotech stocks got a jump-start this morning but peaked quickly then abruptly sold off at about 2p. The IBB ended down 1.33% to 268.79 off recent five-day highs of $274 and considerably off post-election highs of $293.
In this article: BMY, BCRX, IBB, CLVS, GILD, XBI, XLV, SUPN, TSRO
Read
EC 5 Stock Picks Ahead Of World Mental Health Day
Article By: Arpita Dutt Friday, October 7, 2016 2:08 PM EST
The market potential for drugs targeting mental health disorders is huge.
In this article: GWPH, SHPG, JNJ, SUPN, AGN
Read
5 Small Caps For Momentum Investors - 19 September, 2016
Article By: Jim Van Meerten Monday, September 19, 2016 1:10 PM EST
Today's watch list includes: Zeltiq Aesthetics, Supernus Pharma, Mimedx, Marcus and IIVI Inc.
In this article: ZLTQ, SUPN, MCS, IIVI, MDXG
Read
4 Undervalued Biotech Stocks To Buy Today
Article By: Bret Jensen Tuesday, June 7, 2016 10:00 PM EST
The recent brutal bear market in the biotech sector reminded investors in this lucrative but volatile space the imperative importance of risk management when investing in this industry.
In this article: DVAX, MACK, SUPN, ABBV Also: AZN
Read
Today's 5 Best Small Caps - July 23, 2015
Article By: Jim Van Meerten Thursday, July 23, 2015 8:44 PM EST
Today's list includes Lending Tree, Amedisys, Supernus Pharmaceutical, AMN Healthcare Services, and Depomed.
In this article: AHS, DEPO, TREE, AMED, SUPN
Read
CPHD Receives FDA Clearance For Xpert Flu/RSV XC; SUPN Receives Issuance Of Fifth US Patent
Article By: BioMedReports Tuesday, November 25, 2014 3:27 AM EST
CPHD announced it has received clearance from the U.S. FDA to market its Xpert®, SUPN, announced the issuance of a fifth patent (number 8,889,191) by the United States Patent and Trademark Office (USPTO), its novel once-daily extended-release topiramate product.
In this article: CPHD, SUPN
Read
1 to 11 of 11 Posts